Takahisa Gono

Nippon Medical School Hospital — Japan

Medicine · Health Sciences

22h-index1.7kcitations104works1.62yr avg
OpenAlex↗ORCID↗Google Scholar↗Lab page↗

Accepting Students?

No reports yet. Know if this professor is taking students?

Research Topics

Inflammatory Myopathies and Dermatomyositis(45), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis(18), Eosinophilic Disorders and Syndromes(17), Amyloidosis: Diagnosis, Treatment, Outcomes(14), Systemic Lupus Erythematosus Research(12)

Publications98 total

Analytical performance of commercial myositis-specific autoantibody tests evaluated against immunoprecipitation assays as a reference standard: A systematic review and meta-analysis
Seminars in Arthritis and Rheumatism·2025· 3 citedOpen Access
POS0177 IMPACT OF GLUCOCORTICOID TAPERING SPEED ON RENAL OUTCOMES IN PROLIFERATIVE LUPUS NEPHRITIS: A MULTICENTRE RETROSPECTIVE STUDY
Annals of the Rheumatic Diseases·2025Open Access
POS1022 EVALUATION OF PATIENT-REPORTED OUTCOMES FOR PATIENTS WITH MYOSITIS-ASSOCIATED INTERSTITIAL LUNG DISEASE: A JAPANESE PROSPECTIVE MULTICENTRE REGISTRY STUDY
Annals of the Rheumatic Diseases·2025Open Access
ABS0428 CANCER SCREENING STRATEGIES FOR PATIENTS WITH IDIOPATHIC INFLAMMATORY MYOPATHIES: THE 2023 IMACS GUIDELINE VS. REAL-WORLD PRACTICE IN A JAPANESE MYOSITIS REFERRAL CENTER
Annals of the Rheumatic Diseases·2025Open Access
Impact of glucocorticoid tapering speed on renal outcomes in proliferative lupus nephritis: a multicentre retrospective study
Lara D. Veeken·2025· 2 cited
Seroconversion of Rheumatoid Factor Prior to the Onset of Rheumatoid Arthritis in Patients With Interstitial Lung Disease: A Single‐Center Retrospective Case Series
International Journal of Rheumatic Diseases·2024Open Access
Predictive and diagnostic biomarkers for cytomegalovirus infection in patients with rheumatic musculoskeletal diseases treated by high-dose glucocorticoid therapy: multicentre, prospective cohort study
Clinical and Experimental Rheumatology·2024
Mosaic loss of chromosome Y characterizes late-onset rheumatoid arthritis and contrasting associations of polygenic risk score based on age at onset.
2024· 1 citedOpen Access
Different phenotypic manifestations between Brazilian and Japanese anti-MDA5 antibody-positive dermatomyositis: an international tricentric longitudinal study
Clinical and Experimental Rheumatology·2024· 1 citedOpen Access
POS0233 DISTINCT CYTOKINE PROFILE WITH ELEVATED TYPE I/II/III INTERFERONS IN CIRCULATION FROM PATIENTS WITH ANTI-MDA5 ANTIBODY-POSITIVE DERMATOMYOSITIS
Annals of the Rheumatic Diseases·2024
POS1299 RANDOMIZED PLACEBO-CONTROLLED TRIAL TO EVALUATE EFFICACY AND SAFETY OF SUBCUTANEOUS ABATACEPT IN ADULTS WITH ACTIVE IDIOPATHIC INFLAMMATORY MYOPATHY: OUTCOMES FOR JAPANESE STUDY PARTICIPANTS
Annals of the Rheumatic Diseases·2024
Lung ultrasound in the assessment of interstitial lung disease in patients with connective tissue disease: Performance in comparison with high-resolution computed tomography
Modern Rheumatology·2024· 12 citedOpen Access
DIFFERENT PHENOTYPIC MANIFESTATIONS BETWEEN BRAZILIAN AND JAPANESE ANTI-MDA5 ANTIBODY-POSITIVE DERMATOMYOSITIS: AN INTERNATIONAL TRICENTRIC LONGITUDINAL STUDY
2024Open Access
Clinical phenotyping in patients with anti-synthetase antibodies using cluster analysis
Rheumatology Advances in Practice·2024· 3 citedOpen Access
Prognostic Role of Interferon‐λ3 in Anti–Melanoma Differentiation–Associated Gene 5–Positive <scp>Dermatomyositis‐Associated</scp> Interstitial Lung Disease
Arthritis & Rheumatology·2023· 12 cited
Dissociating Autoantibody Responses against Ro52 Antigen in Patients with Anti-Synthetase or Anti-MDA5 Antibodies
Diagnostics·2023· 1 citedOpen Access
The Role of Environmental Factors in the Development of Idiopathic Inflammatory Myopathies: a Narrative Review
Current Rheumatology Reports·2023· 1 cited
Phase 3, multicentre, randomised, double-blind, placebo-controlled, parallel-group study of ustekinumab in Japanese patients with active polymyositis and dermatomyositis who have not adequately responded to one or more standard-of-care treatments
RMD Open·2023· 6 citedOpen Access
POS0971 A COMPARISON OF MYOSITIS AUTOANTIBODY AND CLINICAL CHARACTERISTICS AMONG RACIAL GROUPS IN ASIA AND AUSTRALASIA – A COLLABORATIVE MULTICENTRE EFFORT BY THE APLAR MYOSITIS SIG
Annals of the Rheumatic Diseases·2023Open Access
New paradigm in the treatment of myositis-associated interstitial lung disease
Expert Review of Respiratory Medicine·2023· 3 cited
page 1 of 5Next →

Frequent Co-authors

Shu‐ichi Ikeda(24), Masayuki Matsuda(23), Masataka Kuwana(18), Yasuhiro Shimojima(16), Shinji Sato(8), Wataru Ishii(8), Kenichi Masui(6), Naoshi Nishina(5), Yuko Kaneko(5), Ko‐ichi Tazawa(5), Takuhiro Yoshida(5), Yoshinobu Hoshii(5), Yasushi Kawaguchi(4), Atsushi Kawakami(4), Kei Ikeda(4), Shinjiro Kaieda(4), Yutaka Okano(4), Hideto Kameda(4), Hiroshi Morita(4), Kenichi Hoshi(4)